Craig Davidson Peiris, MD | |
University Of Texas Medical Branch 301 University Blvd, Galveston, TX 77555-0001 | |
(409) 772-1221 | |
Not Available |
Full Name | Craig Davidson Peiris |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | University Of Texas Medical Branch 301 University Blvd, Galveston, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023754892 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | BP10079542 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Craig Davidson Peiris, MD Department Of Anesthesiology 301 University Blvd, Galveston, TX 77555-0877 Ph: (409) 772-1221 | Craig Davidson Peiris, MD University Of Texas Medical Branch 301 University Blvd, Galveston, TX 77555-0001 Ph: (409) 772-1221 |
News Archive
If health officials and media prognosticators are accurate, this coming winter may bring with it one of the most sweeping, deadly outbreaks of killer flu that the world has ever seen.
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart's MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient's own muscle. MyoCell® has been tested successfully on patients in four clinical trials.
Acorda Therapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs (PCNSD) Advisory Committee voted 12 to 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated substantial evidence of effectiveness as a treatment to improve walking in people with multiple sclerosis (MS) and voted 10 to 2 (1 abstention) that it is clinically meaningful and can be safe for use.
› Verified 4 days ago
Sommer Kirsch Causey, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-1221 Fax: 409-772-1224 | |
Heather Tisdale, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 | |
Riley William Baker, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-266-7856 | |
Fernando Alquicira-macedo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd # 2-a, Galveston, TX 77555 Phone: 409-772-1221 Fax: 409-772-1224 | |
Asle Aarsland, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 | |
Erin Michelle Vigil, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-1221 |